Overexpression of human apolipoprotein B-100 induces severe neurodegeneration in transgenic mice.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Proteome Research

• Publication date

  2008-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/pr7006329PMID 18473452
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease

  2008cited by this paper
• Lipolysis products from triglyceride-rich lipoproteins increase endothelial permeability, perturb zonula occludens-1 and F-actin, and induce apoptosis.

  2007cited by this paper
• Hypercholesterolemia increases myocardial oxidative and nitrosative stress thereby leading to cardiac dysfunction in apoB-100 transgenic mice.

  2007cited by this paper
• Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer's disease mouse models with abundant A beta in plasma.

  2006cited by this paper
• The astroglial-derived S100beta protein stimulates the expression of nitric oxide synthase in rodent macrophages through p38 MAP kinase activation.

  2006cited by this paper
• Cardiovascular disease and Alzheimer's disease: common links

  2006cited by this paper
• Syntaxin 1A promotes the endocytic sorting of EAAC1 leading to inhibition of glutamate transport

  2006cited by this paper
• Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis.

  2006cited by this paper
• Dementia and Alzheimer's Disease Incidence in Relationship to Cardiovascular Disease in the Cardiovascular Health Study Cohort

  2005cited by this paper
• Impairment of redox state and dopamine level induced by alpha-synuclein aggregation and the prevention effect of hsp70.

  2005cited by this paper
• Is there a characteristic lipid profile in Alzheimer's disease?

  2005cited by this paper
• Glutamate Metabolizing Enzymes in Prefrontal Cortex of Alzheimer’s Disease Patients

  2005cited by this paper
• Astrocytic nitric oxide triggers tau hyperphosphorylation in hippocampal neurons.

  2004cited by this paper
• Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts

  2003cited by this paper
• Alzheimer's disease: the cholesterol connection

  2003cited by this paper
• Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology.

  2001cited by this paper
• Aortic atherosclerosis at middle age predicts cerebral white matter lesions in the elderly.

  2000cited by this paper
• Apoptosis in neurodegenerative disorders

  2000cited by this paper
• Identification of syntaxin 1A as a novel binding protein for presenilin-1.

  2000cited by this paper
• Neuroprotection by glutamine synthetase.

  2000cited by this paper
• Cerebral Ischemia and Seizures Induce Tyrosine Phosphorylation of PYK2 in Neurons and Microglial Cells

  2000cited by this paper
• Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients.

  2000cited by this paper
• Increased apolipoprotein B serum concentration in Alzheimer's disease

  1999cited by this paper
• Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons

  1999cited by this paper
• Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels.

  1998cited by this paper
• Phosphorylation of stathmin modulates its function as a microtubule depolymerizing factor

  1998cited by this paper
• S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions.

  1994cited by this paper
• Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice.

  1994cited by this paper
• Hyperactivation of Signal Transduction Systems in Alzheimer's Disease a

  1993cited by this paper
• Protein and peptide binding and stimulation of in vitro lysosomal proteolysis by the 73-kDa heat shock cognate protein.

  1992cited by this paper
• Apolipoprotein B, the major protein component of triglyceride-rich and low density lipoproteins.

  1992cited by this paper
• Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer's disease.

  1988cited by this paper
• RARE imaging: A fast imaging method for clinical MR

  1986cited by this paper

• Plasma apolipoproteins and memory function in alcohol use disorder: Findings in male C57BL/6J mice and men suggest a role for APOAI

  2025cites this paper
• Serum Lipid Biomarkers for the Diagnosis and Monitoring of Neuromyelitis Optica Spectrum Disorder: Towards Improved Clinical Management

  2025cites this paper
• Lipid trajectories improve risk models for Alzheimer’s disease and mild cognitive impairment

  2024cites this paper
• Lipid Trajectories Improve Risk Models for Alzheimer’s Disease and Mild Cognitive Impairment

  2024cites this paper
• Elucidating the Mechanisms of Sodium Benzoate in Alzheimer Disease: Insights from Quantitative Proteomics Analysis of Serum Samples

  2023cites this paper
• Emerging Links between Nonalcoholic Fatty Liver Disease and Neurodegeneration

  2023cites this paper
• Exercise training worsens cardiac performance in males but does not change ejection fraction and improves hypertrophy in females in a mouse model of metabolic syndrome

  2022cites this paper
• A New Hypothesis for Alzheimer’s Disease: The Lipid Invasion Model

  2022cites this paper
• Serum lipid traits and the risk of dementia: A cohort study of 254,575 women and 214,891 men in the UK Biobank

  2022cites this paper
• Brain Endothelial Cells in Contrary to the Aortic Do Not Transport but Degrade Low-Density Lipoproteins via Both LDLR and ALK1

  2022cites this paper
• DHA Ameliorates Cognitive Ability, Reduces Amyloid Deposition, and Nerve Fiber Production in Alzheimer’s Disease

  2022cites this paper
• A Novel Panel of Plasma Proteins Predicts Progression in Prodromal Alzheimer’s Disease

  2022cites this paper
• Comparison of cognitive impairments with lipid profiles and inflammatory biomarkers in unipolar and bipolar depression.

  2022cites this paper
• Age-Related Inflammatory Balance Shift, Nasal Barrier Function, and Cerebro-Morphological Status in Healthy and Diseased Rodents

  2021cites this paper
• Sialic Acid Ameliorates Cognitive Deficits by Reducing Amyloid Deposition, Nerve Fiber Production, and Neuronal Apoptosis in a Mice Model of Alzheimer’s Disease

  2021cites this paper
• Association between cognitive impairment and apolipoprotein A1 or apolipoprotein B levels is regulated by apolipoprotein E variant rs429358 in patients with chronic schizophrenia

  2021cites this paper
• Repositioning medication for cardiovascular and cerebrovascular disease to delay the onset and prevent progression of Alzheimer’s disease

  2020cites this paper
• Alzheimer’s disease and type 2 diabetes mellitus: A systematic review of proteomic studies

  2020cites this paper
• Cerebrovascular Changes and Neurodegeneration Related to Hyperlipidemia: Characteristics of the Human ApoB-100 Transgenic Mice

  2020cites this paper
• Association of Early-Onset Alzheimer Disease With Elevated Low-density Lipoprotein Cholesterol Levels and Rare Genetic Coding Variants of APOB.

  2019cites this paper
• Dynamic changes in the brain protein 1 interaction network correlates with 2 progression of Aβ42 pathology in 3 Drosophila 4

  2019cites this paper
• Acidifying endolysosomes prevented LDL-induced amyloidogenesis

  2019cites this paper
• Inflammation as a Possible Link Between Dyslipidemia and Alzheimer's Disease.

  2018cites this paper
• Tracking dynamic changes in Alzheimer’s disease brain proteome reveals ageing-independent damage in Drosophila

  2018cites this paper
• Acidifying Endolysosomes Prevented Low-Density Lipoprotein-Induced Amyloidogenesis

  2018cites this paper
• Cerebrovascular Pathology in Hypertriglyceridemic APOB-100 Transgenic Mice

  2018influential citation
• Ataxia telangiectasia alters the ApoB and reelin pathway

  2018cites this paper
• Dynamic changes in the brain protein interaction network correlates with progression of Aβ42 pathology in Drosophila

  2018cites this paper
• Longitudinal monitoring of sex related in vivo metabolic chang- es in the brain of Alzheimer’s disease transgenic mouse using magnetic resonance spectrosco- py

  2018cites this paper
• Decreased plasma C‐reactive protein levels in APOE ε4 allele carriers

  2018cites this paper
• Low density lipoprotein increases amyloid precursor protein processing to amyloidogenic pathway in differentiated SH-SY5Y cells

  2017cites this paper
• Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20‐year follow‐up of the Swedish AMORIS cohort

  2017cites this paper
• Mouse models to study the effect of cardiovascular risk factors on brain structure and cognition

  2016cites this paper
• Neuropathological changes in mouse models of cardiovascular diseases

  2016cites this paper
• Multi-Targeting Derivatives For Alzheimer’s Disease: Utilization of Quinazoline Ring Scaffolds

  2016influential citation
• Cultured cells of the blood–brain barrier from apolipoprotein B-100 transgenic mice: effects of oxidized low-density lipoprotein treatment

  2015cites this paper
• An apolipoprotein B100 mimotope prevents obesity in mice

  2015cites this paper
• Role of endolysosomes and cholesterol in the pathogenesis of Alzheimer's disease: Insights into why statins might not provide clinical benefit.

  2014cites this paper
• Amyloid beta accumulation in HIV-1 infected brain: the role of altered cholesterol homeostasis.

  2014cites this paper
• Role of LDL cholesterol and endolysosomes in amyloidogenesis and Alzheimer's disease.

  2014cites this paper
• Longitudinal Monitoring of Sex-Related in vivo Metabolic Changes in the Brain of Alzheimer's Disease Transgenic Mouse Using Magnetic Resonance Spectroscopy

  2013cites this paper
• Impact of ApoB-100 expression on cognition and brain pathology in wild-type and hAPPsl mice.

  2013cites this paper
• Mouse Models to Study the Effect of Cardiovascular Risk Factors on Brain Structure and Cognition

  2013cites this paper
• iTRAQ and multiple reaction monitoring as proteomic tools for biomarker search in cerebrospinal fluid of patients with Parkinson's disease dementia.

  2012cites this paper
• Potential biomarkers in psychiatry: focus on the cholesterol system

  2012cites this paper
• Plasma Apolipoprotein Levels Are Associated with Cognitive Status and Decline in a Community Cohort of Older Individuals

  2012cites this paper
• ApoB100/LDLR-/- Hypercholesterolaemic Mice as a Model for Mild Cognitive Impairment and Neuronal Damage

  2011cites this paper
• ULTRASTRUCTURAL MALFORMATIONS OF THE CEREBRAL MICROVESSELS IN PATHOLOGICAL CONDITIONS AN ELECTRON MICROSCOPIC STUDY

  2010cites this paper
• Cholesterol metabolism and transport in the pathogenesis of Alzheimer’s disease

  2009cites this paper
• Hippocampal gene expression changes during age-related cognitive decline.

  2009cites this paper
• Capillary injury in the ischemic brain of hyperlipidemic, apolipoprotein B-100 transgenic mice.

  2009cites this paper